Skip to main content
メニュー
Revvity logo
Contact us

Loading...

JP
Search all

Loading...

Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

australia.webp Australia
austria.webp Austria
belgium.webp Belgium
brazil.webp Brazil *
canada.webp Canada
china.webp China *
denmark.webp Denmark
finland.webp Finland
france.webp France
germany.webp Germany
hong-kong.webp Hong Kong (China) *
india.webp India *
ireland.webp Ireland
italy.webp Italy
japan.webp Japan *
luxembourg.webp Luxembourg
mexico.webp Mexico *
netherlands.webp Netherlands
norway.webp Norway
philippines.webp Philippines *
republic of korea.webp Republic of Korea *
singapore.webp Singapore *
spain.webp Spain
sweden.webp Sweden
switzerland.webp Switzerland
thailand.webp Thailand *
uk.webp United Kingdom
usa.webp United States
Breadcrumb
...
  • ホーム
  • Induced regulatory T cell suppression assay for compound screening
Induced regulatory T cell suppression assay for compound screening
Application Note

Induced regulatory T cell suppression assay for compound screening

To investigate immunomodulators on iTreg function, compound screening can be a valuable tool to help decipher the immunological profile of drug target candidates.

In this application note, we present our rapid high-throughput in vitro functional assay to assess the effect of compounds on iTreg function to enhance or inhibit their suppressive activity on T cells.

This assay can be run complementary to our previously developed iTreg polarization assay to elucidate the overall activity of compounds on iTreg biology.

For research use only. Not for use in diagnostic procedures.

Download Resource

Induced regulatory T cell suppression assay for compound screening

Download Application Note
Revvity Logo

©2025 Revvity - All rights reserved

Revvity is a trademark of Revvity, Inc. All other trademarks are the property of their respective owners.